×
About 118 results

ALLMedicine™ Angiosarcoma Of The Scalp Center

Research & Reviews  59 results

Imaging findings of cutaneous angiosarcoma of the scalp: Comparison with cutaneous squa...
https://doi.org/10.1177/1971400921998941
The Neuroradiology Journal; Kawaguchi M, Kato H et. al.

Mar 4th, 2021 - This study aimed to evaluate imaging findings of cutaneous angiosarcoma (cAS) of the scalp compared with those of cutaneous squamous cell carcinoma (cSCC). This study included 15 patients with primary cAS and 10 with primary cSCC of the scalp. Sev...

Dosimetric Comparison of Helical Tomotherapy, Volumetric-Modulated Arc Therapy, and Int...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871283
Technology in Cancer Research & Treatment; Mizuno T, Tomita N et. al.

Feb 1st, 2021 - We compared radiotherapy plans among helical tomotherapy (HT), volumetric-modulated arc therapy (VMAT), and intensity-modulated proton therapy (IMPT) for angiosarcoma of the scalp (AS). We conducted a planning study for 19 patients with AS. The cl...

Novel strategy with the automatic non-coplanar volumetric-modulated arc therapy for ang...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367225
Radiation Oncology (London, England); Inui S, Ueda Y et. al.

Jul 18th, 2020 - Total scalp irradiation presents technical and dosimetric challenges. While reports suggest that HyperArc, a new stereotactic radiosurgery planning technique applied to non-coplanar volumetric-modulated arc therapy (VMAT) technique, is associated ...

A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated pri...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359578
BMC Cancer; Oashi K, Shibata T et. al.

Jul 14th, 2020 - Paclitaxel is a standard of care for patients with primary cutaneous angiosarcoma of the scalp and face. However, no standard second-line treatment for paclitaxel-resistant patients has ever been established. Since primary cutaneous angiosarcoma e...

Is Proton Beam Radiotherapy Worthwhile in the Management of Angiosarcoma of the Scalp?
https://doi.org/10.21873/anticanres.14114
Anticancer Research; Vitolo V, Barcellini A et. al.

Mar 6th, 2020 - In inoperable patients, the management of angiosarcoma of the scalp is challenging. Due to intrinsic, dosimetric and radiobiological properties, proton beam radiotherapy may be an effective and safe option to offer to these difficult-to-cure patie...

see more →

Clinicaltrials.gov  59 results

Imaging findings of cutaneous angiosarcoma of the scalp: Comparison with cutaneous squa...
https://doi.org/10.1177/1971400921998941
The Neuroradiology Journal; Kawaguchi M, Kato H et. al.

Mar 4th, 2021 - This study aimed to evaluate imaging findings of cutaneous angiosarcoma (cAS) of the scalp compared with those of cutaneous squamous cell carcinoma (cSCC). This study included 15 patients with primary cAS and 10 with primary cSCC of the scalp. Sev...

Dosimetric Comparison of Helical Tomotherapy, Volumetric-Modulated Arc Therapy, and Int...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871283
Technology in Cancer Research & Treatment; Mizuno T, Tomita N et. al.

Feb 1st, 2021 - We compared radiotherapy plans among helical tomotherapy (HT), volumetric-modulated arc therapy (VMAT), and intensity-modulated proton therapy (IMPT) for angiosarcoma of the scalp (AS). We conducted a planning study for 19 patients with AS. The cl...

Novel strategy with the automatic non-coplanar volumetric-modulated arc therapy for ang...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367225
Radiation Oncology (London, England); Inui S, Ueda Y et. al.

Jul 18th, 2020 - Total scalp irradiation presents technical and dosimetric challenges. While reports suggest that HyperArc, a new stereotactic radiosurgery planning technique applied to non-coplanar volumetric-modulated arc therapy (VMAT) technique, is associated ...

A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated pri...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359578
BMC Cancer; Oashi K, Shibata T et. al.

Jul 14th, 2020 - Paclitaxel is a standard of care for patients with primary cutaneous angiosarcoma of the scalp and face. However, no standard second-line treatment for paclitaxel-resistant patients has ever been established. Since primary cutaneous angiosarcoma e...

Is Proton Beam Radiotherapy Worthwhile in the Management of Angiosarcoma of the Scalp?
https://doi.org/10.21873/anticanres.14114
Anticancer Research; Vitolo V, Barcellini A et. al.

Mar 6th, 2020 - In inoperable patients, the management of angiosarcoma of the scalp is challenging. Due to intrinsic, dosimetric and radiobiological properties, proton beam radiotherapy may be an effective and safe option to offer to these difficult-to-cure patie...

see more →